DS
BCAB icon

David Shaw’s BioAtla BCAB Stock Holding History

David Shaw’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,312
Closed -$614K – 5184
2022
Q2 		$614K Sell
4,312
-1,725
-29% -$275K ﹤0.01% 3978
2022
Q1 		$1.51M Buy
6,037
+5,442
+915% +$2.28M ﹤0.01% 3571
2021
Q4 		$584K Buy
+595
New +$761K ﹤0.01% 4316

Other funds holding BCAB

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

David Shaw's BCAB Position: Q3 2022 in Review

David Shaw sold out of BioAtla (BCAB) in Q3 2022, closing a stake of 4,312 shares — an estimated $614K sold.

David Shaw first reported a position in BCAB in Q4 2021 and held it in 3 quarters. The position peaked at $1.51M in Q1 2022. 73 funds tracked by Wall St. Rank hold BCAB as of Q3 2022.

  • David Shaw reported no remaining BioAtla position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 4,312 BioAtla shares in Q3 2022, an estimated $614K.
  • David Shaw first reported a position in BioAtla in Q4 2021 and held it in 3 quarters.
  • David Shaw's BioAtla position peaked at $1.51M in Q1 2022.
  • 73 funds tracked by Wall St. Rank held BioAtla as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.